World of DTC Marketing

MAY 19, 2021

According to CNBC “AbbVie workers say they worry that the company is putting profits ahead of safety and the health of its U.S. The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. Why the increase?

Pharma 181

Pharma Prescription Patients Pharmaceutical 181

Medgadget

MAY 2, 2023

She started working on this technology around 2013 after realizing the dire need for an alternative solution for mental disorders, and through realization that science can provide more answers. During this time, two additional studies ended successfully and were published, further validating the clinical safety and effectiveness.

Side effects 86

Side effects Prescription Healthcare Healthcare 86

European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf. 1435 (“Affordable Prescriptions for Patients Act of 2021”), [link] gov/bill/117th-congress/senate-bill/1435/text; H.R. Actavis, 570 U.S.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Pharmaceutical Technology

OCTOBER 25, 2022

From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 Improved convenience and safety. Replacing two or three pills with a single FDC drug product also translates into less time spent filling (and refilling) prescriptions. More FDC products flowing into pharma pipelines. The numbers tell the story.

Manufacturing 52

Manufacturing Physicians Prescription Pharmaceutical 52

PM360

OCTOBER 22, 2024

For instance, one study found that from 1993 to 2013, only 5% of all clinical trials in respiratory diseases included members of racial or ethnic minority groups. The barriers patients experience in accessing treatment: The journey to therapy can go well beyond a doctor’s appointment and a prescription.

Side effects 52

Side effects Patients Prescription Healthcare 52

Pharmaceutical Technology

OCTOBER 10, 2022

Since the publication of the fifth Diagnostic and Statistical Manual of Mental Disorders in 2013, both conditions are grouped under the term FSIAD, which includes reduced arousal and interest. One Phase II trial was completed back in 2013, as per ClinicalTrials.gov.

Pharmacology 59

Pharmacology Side effects FDA Safety 59